E-mediated allergies to food proteins. (ii) Food protein-induced enterocolitis syndrome. (iii) Eosinophilic disorders, including eosinophilic esophagitis, eosinophilic gastroenteritis, eosinophilic colitis, and post-transplant eosinophilic disorders. (D) Inflammatory or immune mediated conditions of the alimentary tract, including the following: (i) Inflammatory bowel disease, including Crohn’s disease, ulcerative colitis, and indeterminate colitis. (ii) Gastroesophageal reflux disease that is nonresponsive to standard medical therapies. (E) Any other disease or condition determined appropriate by the Secretary, in consultation with appropriate scientific entities, such as the Agency for Healthcare Research and Quality. (4) (A) In this subsection, the term low protein modified food product means a type of medical food that is modified to be low in protein and formulated for oral consumption for individuals with inborn errors of protein metabolism. (B) Such term does not include foods that are naturally low in protein, such as some fruits or vegetables. . (3) Payment Section 1833(a)(1) of the Social Security Act ( 42 U.S.C. 1395l(a)(1) ) is amended— (A) by striking and before (GG)